dr james c wittig, orthopedic oncologist, new york, new jersey
Patient Education
Chemotherapy

Chemotherapy is a type of medicine or drugs used to kill cancer cells or cancerous tumors. In general, chemotherapy is not used for benign tumors. There are many types of chemotherapy medicines. The type of chemotherapy that is given depends on the type of tumor. Some chemotherapy medicines are given on an outpatient basis (you come into the hospital or chemotherapy infusion center and the chemotherapy medicine is given intravenously and then you go home the same day). Some chemotherapy medicines rewuire you to stay in the hospital for a few days to receive them. Occasionally, chemotherapy medicines are administered by mouth in a pill form or tablet. If the chemotherapy medicine is administered intravenously, it is usually administered through a port that must be surgically placed into one of the large veins. The port remains in place until the chemotherapy course is finished. There are many side effects associated with chemotherapy such as nausea, vomiting, reduced blood cell counts, anemia, bleeding problems, infections, fevers, nerve problems, heart problems, kidney problems, hearing loss, bladder problems hair loss, sterility. The types and magnitude of complications depends on the specific type of chemotherapy medicine. The chemotherapy agents are administered according to a schedule so that a certain doseage is administered over a defined period of time (months, etc). This provides for optimal doses that are effective at killing the cancer cells. Patients are followed closely for complications and appropriate measures are taken to reduce the likelihood and magnitude of complications. There are very effective agents to prevent nausea and vomiting. Growth factors can be given to increase blood counts and minimize anemia, low white blood cell counts (infections/fevers) and low platelets (bleeding). Transfusions may be required. The heart, kidneys and hearing are tested prior to receiving any chemotherapy and they are checked periodically to ensure that no problems are developing. If these problems occur, the specific medication causing the problem may be reduced in doseage or stopped. A different medication may be substituted.

The most common chemotherapy medications used in the treatment of bone and soft tissue sarcomas include doxorubicin (Adriamycin), ifosfamide, cyclophosphamide, cisplatin, etoposide (VP-16), methotrexate, vincristine, vinblastine, actinomycin-D, gemcitabine. Mesna may be administered with ifosfamide or cyclophosphamide to prevent bladder problems (hemorrhagic cystitis). Leucovorin is administered with methotrexate to rescue the body's normal cells from the toxic effects of methotrexate. Dexrazoxane may be administered with doxorubicin to help protect the heart against any potential bad effects from the doxorubicin. G-CSF (granulocyte colony stimulating factor) is a growth factor that is used to stimulate white blood cell production and may be given to increase the patient's white blood cells which reduces the chance of developing a fever and infection. It also increases the white cell count so the patient can resume the next dose of chemotherapy as soon as possible. Erythropoietin is a red blood cell growth factor that helps increase the number of red cells (improves the hematocrit) and reduces anemia. There are also growth factors that can be used to increase a patients platelet count.

Chemotherapy is the administration of certain toxic drugs in an attempt to kill cancer cells and cure patients of their cancer, shrink tumors to facilitate surgical resection or prolong a patient's life. Chemotherapy is typically administered for high grade bone sarcomas. It is usually given before surgery (preoperative chemotherapy=neoadjuvant chemotherapy=induction chemotherapy) to try to kill the tumor before taking it out. The terms induction chemotherapy and neoadjuvant chemotherapy refer to giving the chemotherapy before surgery. Giving chemotherapy before surgery makes it easier to remove the tumor and makes it less likely for the tumor to come back in the area where it was removed. At the same time, any microscopic tumor cells that have spread throughout the body are killed. Certain tumors may shrink dramatically following chemotherapy which makes the surgery easier. Less normal tissue is removed. Preoperative chemotherapy also permits us to examine the response that the tumor had to the chemotherapy which helps us estimate the patient's prognosis (it helps us estimate the response of the microscopic tumor cells that have already spread). Preoperative or induction chemotherapy is largely responsible for our present day ability to save 90%-95% of limbs with high grade sarcomas instead of performing amputations. Amputations for high grade bone sarcomas are rarely performed nowadays.

For high grade bone sarcomas, chemotherapy is also usually given postoperatively. When it is given postoperatively, it is referred to as adjuvant chemotherapy. The same chemotherapy agents are used before and after surgery. The purpose of chemotherapy is to kill any tumor cells that have spread throughout the body that can grow and kill the patient. By killing or eradicating these cells, the patient can be cured of the cancer. The entire chemotherapy regimen may require 6 months to 12 months to complete. Some chemotherapy agents require a hospital admission for a few days in order to administer the medications. The following chemotherapy drugs may be used in the treatment of sarcomas: Adriamycin (doxorubicin), ifosfamide, cisplatin, high dose methotrexate, cyclophosphamide, vincristine, actinomycin-D, etoposide. There are complications that are specific to each type of medication. These complications should be thoroughly discussed with the medical oncologist. Some of the general complications or side effects include: hair loss, nausea and vomiting, mucositis, myelosuppression/decrease in the blood counts (neutropenia=drop in white blood cells; anemia=drop in red blood cells; thrombocytopenia=drop in platelets), cardiac dysfunction, hearing loss, kidney failure, neuropathy. Many of these side effects and complications can be minimized with specific medications. Prior to initiating chemotherapy several blood tests will be ordered along with a hearing test and an echocardiogram (asseses the function of the heart). Blood tests will be required frequently throughout the course of the chemotherapy regimen to follow kidney function and blood counts. A special intravenous line will be placed (port-a-cath or groshong) that can stay in place for prolonged periods. This line is directed into the large veins that empty into the cardiopulmonary circulation. It is necessary to place these lines so the chemotherapy can be administered directly into the large veins. Infusion of chemotherapy agents into small veins causes destruction of the small veins. Additionally some agents may spill under the skin and cause skin damage. The patient and family members must be aware that these ports can get infected when the patient's white blood cell count drops. Any fever that develops during chemotherapy must be reported to the oncologist, the patient will be admitted, cultures of the blood obtained along with a chest X-ray and urinalysis to check for bacteria. The patient will be started immediately on intravenous antibiotics. If a line gets infected postoperatively in a patient who has had a prosthetic replacement, the line should be removed. Bacteria can live for long periods on the part of the line that is in the venous sytem. Intravenous antibiotics may not eradiacte the bacteria and the bacteria can spread to the prosthesis and cause a severe limb threatening infection that requires additional surgery and is difficult to cure without removing the prosthesis (impossible to cure with intravenous antibiotics alone without removing the prosthesis.

Copyright 2014 by Tumorsurgery.org
   
     
   
    
 
 
   Website Translation Widget

    Google+